Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q99523
UPID:
SORT_HUMAN
Alternative names:
100 kDa NT receptor; Glycoprotein 95; Neurotensin receptor 3
Alternative UPACC:
Q99523; B4DWI3; C0JYZ0; Q8IZ49
Background:
Sortilin, also known as the 100 kDa NT receptor, Glycoprotein 95, or Neurotensin receptor 3, plays a pivotal role in cellular processes. It functions as a sorting receptor in the Golgi compartment and as a clearance receptor on the cell surface. Essential for protein transport from the Golgi to lysosomes and endosomes, Sortilin facilitates the trafficking of lysosomal proteins by binding to them in the Golgi, leading to their transport to prelysosomal compartments. Additionally, it mediates neuronal apoptosis through the endocytosis of proBDNF and proNGFB, acts as a receptor for neurotensin, and is involved in the mineralization of the extracellular matrix and the formation of GLUT4 storage vesicles in adipocytes.
Therapeutic significance:
Understanding the role of Sortilin could open doors to potential therapeutic strategies.